GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imeik Technology Development Co Ltd (SZSE:300896) » Definitions » Return-on-Tangible-Equity

Imeik Technology Development Co (SZSE:300896) Return-on-Tangible-Equity : 33.73% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Imeik Technology Development Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Imeik Technology Development Co's annualized net income for the quarter that ended in Mar. 2024 was ¥2,110 Mil. Imeik Technology Development Co's average shareholder tangible equity for the quarter that ended in Mar. 2024 was ¥6,255 Mil. Therefore, Imeik Technology Development Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 33.73%.

The historical rank and industry rank for Imeik Technology Development Co's Return-on-Tangible-Equity or its related term are showing as below:

SZSE:300896' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 15.92   Med: 27.99   Max: 58.88
Current: 32.44

During the past 10 years, Imeik Technology Development Co's highest Return-on-Tangible-Equity was 58.88%. The lowest was 15.92%. And the median was 27.99%.

SZSE:300896's Return-on-Tangible-Equity is ranked better than
90.81% of 762 companies
in the Medical Devices & Instruments industry
Industry Median: 1.66 vs SZSE:300896: 32.44

Imeik Technology Development Co Return-on-Tangible-Equity Historical Data

The historical data trend for Imeik Technology Development Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imeik Technology Development Co Return-on-Tangible-Equity Chart

Imeik Technology Development Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.88 17.01 20.08 24.06 32.40

Imeik Technology Development Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.12 37.40 30.36 29.06 33.73

Competitive Comparison of Imeik Technology Development Co's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Imeik Technology Development Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imeik Technology Development Co's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imeik Technology Development Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Imeik Technology Development Co's Return-on-Tangible-Equity falls into.



Imeik Technology Development Co Return-on-Tangible-Equity Calculation

Imeik Technology Development Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1858.475/( (5484.592+5988.13 )/ 2 )
=1858.475/5736.361
=32.40 %

Imeik Technology Development Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=2109.748/( (5988.13+6522.436)/ 2 )
=2109.748/6255.283
=33.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Imeik Technology Development Co  (SZSE:300896) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Imeik Technology Development Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Imeik Technology Development Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Imeik Technology Development Co (SZSE:300896) Business Description

Traded in Other Exchanges
N/A
Address
No. Jia 92 Jianguo Road, 21st, Block C, Shimao Building, Chaoyang District, Beijing, CHN, 100022
Imeik Technology Development Co Ltd is a national enterprise focusing on the research and development, manufacture and sales of biomedical materials. The company's products include Medical Cosmetic Platform; General Surgery Platform; and Biological Technology Platform.

Imeik Technology Development Co (SZSE:300896) Headlines

No Headlines